A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease
Clinical trial NCT07349524 · RECRUITING
Trial details
- NCT number
- NCT07349524
- Sponsor
- Reistone Biopharma Company Limited
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-10
- Primary completion
- 2028-03-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.